Skip to main content
Industry News
FDA OKs AI diabetic retinopathy screening from Eyenuk

The FDA has given 510(k) clearance for Eyenuk to market EyeArt, a screening system that uses artificial intelligence to automatically find vision-threatening diabetic retinopathy in diabetes patients in a single test. EyeArt can produce diagnostic outputs for each eye.

Full Story: